These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4448930)

  • 1. Editorial: Immunosuppression versus immune response.
    Chatterjee J
    J Indian Med Assoc; 1974 Sep; 63(6):199. PubMed ID: 4448930
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity and immunosuppression.
    Chalhoub ES
    J Med Liban; 1973; 26(1):17-20. PubMed ID: 4718004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heterologous antilymphocyte serum on the immunoreactivity of mice].
    Andreson RK
    Biull Eksp Biol Med; 1970 Mar; 69(3):84-7. PubMed ID: 4928082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment].
    Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 7. Concanavalin A. Effects on rat heart allograft survival and immune responses.
    Weil R; Nozawa M; Chernack W; Weber C; Reemtsma K; McIntosh R
    Transplantation; 1974 Jun; 17(6):600-4. PubMed ID: 4597925
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary: modification of immunity and carcinogenesis.
    Haran-Ghera N
    Natl Cancer Inst Monogr; 1972 Dec; 35():211-3. PubMed ID: 4572825
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
    Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
    [No Abstract]   [Full Text] [Related]  

  • 10. [The body's defenses].
    FNIB; 1975 Feb; 53(1):10-1. PubMed ID: 1038379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy and immunosuppression].
    Cleton FJ
    Ned Tijdschr Geneeskd; 1977 Jan; 121(1):18-21. PubMed ID: 834323
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism for prolonged survival of pig renal allografts.
    Perper RJ; Bowersox BE; Van Gorder TJ
    Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase-induced inhibition of transplantation immunity: prolongation of skin allografts in enzyme-treated mice.
    Friedman H; Chakrabarty AK
    Transplant Proc; 1971 Mar; 3(1):826-30. PubMed ID: 4937977
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of transplantation biology and medicine.
    Medawar P
    Transplant Proc; 1969 Mar; 1(1):666-9. PubMed ID: 4944283
    [No Abstract]   [Full Text] [Related]  

  • 15. Some critical remarks and suggestions about antilymphocyte serum.
    Grabar P
    Transplant Proc; 1972 Sep; 4(3):407-13. PubMed ID: 4628101
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer therapy and the immune response of the body].
    Bergol'ts VM
    Vopr Onkol; 1970; 16(12):82-93. PubMed ID: 4932064
    [No Abstract]   [Full Text] [Related]  

  • 17. Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatment.
    Hersh EM; Gutterman JU; Mavligit G; McCredie KB; Bodey GP; Freireich EJ; Rossen RD; Butler WT
    Transplant Proc; 1973 Sep; 5(3):1191-5. PubMed ID: 4728816
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of graft removal and immunosuppression on antibody response to murine histocompatibility antigens.
    Sparks FC; Canty TG; Ting CC; Hammond WG; Heberman RB
    Rev Surg; 1970; 27(5):374. PubMed ID: 4922239
    [No Abstract]   [Full Text] [Related]  

  • 20. [The physiopathology of immune processes. I. Modes of action of immunologic reactions].
    Keitel W
    Z Arztl Fortbild (Jena); 1968 Mar; 62(5):245-9. PubMed ID: 4879491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.